Discussing breast cancer and hormone replacement therapy with women

Pelin Batur, MD
Section of Women’s Health, Department of General Internal Medicine, Gault Women’s Health and Breast Pavilion, The Cleveland Clinic

Holly L. Thacker, MD, FACP
Departments of General Internal Medicine and Obstetrics and Gynecology; Head, Section of Women’s Health, Department of General Internal Medicine, Gault Women’s Health and Breast Pavilion, The Cleveland Clinic; Clinical Associate Professor of Medicine, Penn State University, Hershey, PA

Halle C.F. Moore, MD
Department of Hematology and Medical Oncology, Gault Women’s Health and Breast Pavilion, The Cleveland Clinic

Address: Pelin Batur, MD, Department of Internal Medicine, Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail baturp@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for some of the uses under discussion.

Pelin Batur, MD
Section of Women’s Health, Department of General Internal Medicine, Gault Women’s Health and Breast Pavilion, The Cleveland Clinic

Holly L. Thacker, MD, FACP
Departments of General Internal Medicine and Obstetrics and Gynecology; Head, Section of Women’s Health, Department of General Internal Medicine, Gault Women’s Health and Breast Pavilion, The Cleveland Clinic; Clinical Associate Professor of Medicine, Penn State University, Hershey, PA

Halle C.F. Moore, MD
Department of Hematology and Medical Oncology, Gault Women’s Health and Breast Pavilion, The Cleveland Clinic

Address: Pelin Batur, MD, Department of Internal Medicine, Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail baturp@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for some of the uses under discussion.

Pelin Batur, MD
Section of Women’s Health, Department of General Internal Medicine, Gault Women’s Health and Breast Pavilion, The Cleveland Clinic

Holly L. Thacker, MD, FACP
Departments of General Internal Medicine and Obstetrics and Gynecology; Head, Section of Women’s Health, Department of General Internal Medicine, Gault Women’s Health and Breast Pavilion, The Cleveland Clinic; Clinical Associate Professor of Medicine, Penn State University, Hershey, PA

Halle C.F. Moore, MD
Department of Hematology and Medical Oncology, Gault Women’s Health and Breast Pavilion, The Cleveland Clinic

Address: Pelin Batur, MD, Department of Internal Medicine, Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail baturp@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for some of the uses under discussion.